Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

E

ELVN

Enliven Therapeutics Inc

59.37

Aug 04 • 1:44 PM ET +1.33 (2.29%)

Healthcare Biotechnology USA Mid NASD

Peers: ERAS IDYA TNGX CGON KYMR NUVL BMRN INCY RYTM AXSM

| Held by: VTI IWM VXF IBB IWO SCHA VTWO XPH IHE DFAS

Scroll to Statements

Index	RUT
Market Cap	4.24B
Enterprise Value	3.79B
Income	-98.78M
Sales	0.00M
Book/sh	7.45
Cash/sh	6.33
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	60
IPO	Mar 12, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.97
P/C	9.37
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	40.32
Current Ratio	40.32
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-1.66
EPS next Y	-2.31
EPS next Q	-0.39
EPS this Y	6.59%
EPS next Y	-35.30%
EPS next 5Y	-16.86%
EPS past 3/5Y	46.65% 33.56%
Sales past 3/5Y	- -
EPS Y/Y TTM	13.79%
Sales Y/Y TTM	-
EPS Q/Q	34.03%
Sales Q/Q	-
Earnings	May 07 AMC
EPS/Sales Surpr.	14.34% -

Insider Own	17.87%
Insider Trans	-9.50%
Inst Own	71.55%
Inst Trans	-0.30%
ROA	-25.74%
ROE	-26.64%
ROIC	-21.79%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	11.58%
SMA50	25.79%
SMA200	78.93%
Trades

Shs Outstand	60.89M
Shs Float	58.67M
Short Float	14.75%
Short Ratio	6.49
Short Interest	8.65M
52W High	59.72 -0.59%
52W Low	14.78 301.55%
Volatility	6.15% 5.17%
ATR (14)	2.90
RSI (14)	72.44
Beta	0.30
Rel Volume	1.68
Avg Volume	1.33M
Volume	1,500,933

Perf Week	10.43%
Perf Month	18.71%
Perf Quarter	42.68%
Perf Half Y	110.75%
Perf YTD	285.51%
Perf Year	216.80%
Perf 3Y	227.46%
Perf 5Y	165.99%
Perf 10Y	-
Recom	1.09
Target Price	65.80
Prev Close	58.04
Price	59.37
Change	2.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)